The novel coronavirus (COVID-19) pandemic has brought unprecedented attention to challenges in China’s domestic healthcare system. The report reviews those challenges and examines the efforts of China’s policymakers to address them.
The hearing examines the Chinese government's use of capital markets to advance its technology and defense capabilities and evaluate the risks of U.S. investors' capital being leveraged for such ends. The first panel examines the evolving role of the state in China's capital markets, including the Chinese Communist Party's involvement in corporate governance. The second panel reviews China's…
The U.S.-China Economic and Security Review Commission invites submission of proposals to provide a concise, one-time unclassified report on China’s industrial overcapacity. Proposals must be submitted by March 26, 2021 at 5:30 pm ET.
The hearing evaluates the state of deterrence across the Taiwan Strait and its implications for U.S. interests. The first panel assesses the cross-Strait military balance. The second panel examines the political considerations informing Beijing’s willingness to use force against Taiwan and those informing Taipei’s response. The third panel reviews U.S. policy relevant to Taiwan’s defense,…
The hearing evaluates the state of the U.S.-China relationship, the Chinese Communist Party's goals in the year of its centennial, and the implications for the United States. The first panel offers a net assessment of the current state of U.S.-China political, economic, and security relations heading into 2021. The second panel examines key takeaways from the Fifth Plenum and other recent high-…
China’s ambitious Corporate Social Credit System (CSCS) comprises a nation-wide data-gathering effort intended to regulate corporate behavior. This report describes the policy background, present function, and ultimate vision for this system as identified by the Chinese Communist Party (CCP).